Bibliographic Details
| Title: |
LYMRIT 37-01: UPDATED RESULTS OF A PHASE I/II STUDY OF 177LU-LILOTOMAB SATETRAXETAN, A NOVEL CD37-TARGETED ANTIBODY- RADIONUCLIDE-CONJUGATE IN RELAPSED NHL PATIENTS. |
| Authors: |
Kolstad, A., Madsbu, U., Beasley, M., Bayne, M., Illidge, T., O'Rourke, N., Lagerlöf, I., Hájek, R., Jurczak, W., Willenbacher, E., Blakkisrud, J., Muftuler Løndalen, A., Rojkjaer, L., Baylor Curtis, L., Bloma, M., Turner, S., Bolstad, N., Spetalen, S., Erlanson, M., Nygaard, S. |
| Source: |
Hematological Oncology; Jun2017 Supplement, Vol. 35, p269-270, 2p |
| Database: |
Complementary Index |
